Male |
71 |
52 |
Age at the initial diagnosis of AF (years) |
51.8 |
20–60 |
Age at the time of the present study (years) |
56.7 |
22–65 |
Type of AF at presentation |
|
|
Paroxysmal AF |
88 |
65 |
Persistent AF |
27 |
20 |
Long-lasting persistent AF |
21 |
15 |
Positive family history of AF |
48 |
35 |
History of cardioversion |
112 |
82 |
History of pacemaker |
7 |
5 |
Resting heart rate (beats per minute) |
76.5 |
58-160 |
Systolic blood pressure (mmHg) |
126.4 |
90-136 |
Diastolic blood pressure (mmHg) |
87.2 |
62-89 |
Body mass index (kg/m2) |
22.4 |
20-24 |
Left atrial dimension (mm) |
38 |
30-40 |
Left ventricular ejection fraction |
0.6 |
0.5-0.7 |
Fasting blood glucose (mmol/L) |
4.6 |
3.6-5.8 |
Total cholesterol (mmol/L) |
4.0 |
3.0-5.6 |
Triglycerides (mmol/L) |
1.5 |
0.8-1.7 |
Medications |
|
|
Amiodarone |
101 |
74 |
Warfarin |
29 |
21 |
Digoxin |
23 |
17 |
Beta-blocker |
16 |
12 |
Calcium channel blocker |
11 |
8 |